Pubertal Replacement In Boys Study Nebido and Testoviron Depot Treatment
Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
In this prospective open clinical study, Pubertal Replacement in Boys Study (PRIBS), boys
14-16 years with delayed puberty in terms of slow pubertal progression, were randomized to
SoC treatment with TE: Testostoviron depot® 75 mg intramuscularly (i.m) / month (6
injections), or low dose TU: Nebido® 250mg i.m. / 3 months (2 injections). Our goal was to
implement a study similar to clinical routine.